Panoply™ Human ENPP3 Knockdown Stable Cell Line

Clear cell renal cell carcinoma (ccRCC) is an immune desert tumor. Here, researchers investigated the role of exonucleotide pyrophosphatase/phosphodiesterase 3 (ENPP3) as a potential therapeutic target and immune checkpoint enzyme in ccRCC. Results showed that ENPP3 can be induced by HIF-1α under hypoxic conditions, is highly expressed in ccRCC, and predicts poor prognosis. ENPP3 overexpression accelerates tumor growth, while ENPP3 knockdown or antibody blockade inhibits tumor progression and synergizes with anti-PD-L1 antibodies. Mechanistically, ENPP3 hydrolyzes extracellular cGAMP. ENPP3 deficiency increases extracellular cGAMP levels, expands anti-tumor immune cells (M1 macrophages, cDC1, and cytotoxic T cells), reduces regulatory T cells (Tregs), and induces STING and IFNAR1-dependent type I interferon signaling pathways in macrophages. The antitumor efficacy of ENPP3 blockade can be eliminated by IFNAR1 inhibitors.

ENPP3 is a validated extracellular nucleotidase that hydrolyzes the STING agonist cGAMP. Forced expression of ENPP3 in ACHN and Caki-2 cells reduced extracellular cGAMP levels by 35%–48%, while intracellular levels remained almost unchanged (Figure 1A). Conversely, in ENPP3-knockdown RCC4 and SNU-333 cells, extracellular cGAMP levels increased 1.6 to 1.9-fold (Figure 1B), confirming that ENPP3 selectively degrades extracellular cGAMP. Next, the researchers investigated whether this biochemical change affected tumor growth. ENPP3-knockdown RCC4 xenografts grew significantly slower than the control group (Figure 1C). Importantly, daily intraperitoneal injection of recombinant STING protein (which neutralizes extracellular cGAMP but cannot enter cells) completely reversed the tumor growth defect and significantly restored tumor volume (Figure 1C). Therefore, the antitumor activity of ENPP3 deficiency is mainly mediated by the accumulation of extracellular cGAMP. Tumor flow cytometry analysis 18 days post-transplantation showed that ENPP3 knockdown led to an increase in the proportion of macrophages (Figure 1D), and the STING signaling pathway was mildly activated in M1-like macrophages, manifested as IRF3 phosphorylation (Figure 1E).

Figure 1. ENPP3 modulates the extracellular cGAMP and immune landscape in ccRCC. (Ma J, et al., 2026)